FDA Accepts BLA for ENNUMO (PEGFILGRASTIM-PCCG) by Accord Biopharma
The FDA has accepted the Biologics License Application for ENNUMO, a pegylated form of filgrastim.
Asset / Drug
Drug and asset intelligence for ENUMMO with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.